Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Kersting
Myeloablative T Cell-Depleted alloSCT With Early Sequential Prophylactic Donor Lymphocyte Infusion Is an Efficient and Safe Post-Remission Treatment for Adult ALL
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Donor T-Lymphocyte Infusion for Unrelated Allogeneic Bone Marrow Transplantation With CD3+ T-Cell-Depleted Graft
Bone Marrow Transplantation
Transplantation
Hematology
B-Cell Enrichment and Infusion in CD4+/CD8+ T-Cell Depleted Products for Donor Innate Immune Lymphocyte Infusion: Is Risk of EBV-associated Lymphocyte Post Transplantation Lymphoproliferative Disease a Concern?
Bone Marrow Transplantation
Transplantation
Hematology
Donor Lymphocyte Infusions Induce Durable Responses in Patients With Follicular, Mantle and T Cell Lymphomas Relapsing After an Allosct. An Ebmt-LWP Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
T-Cell-Depleted Allogeneic Bone Marrow Transplantation Followed by Donor Lymphocyte Infusion in Patients With Multiple Myeloma: Induction of Graft-Versus-Myeloma Effect
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Characterization of T Cell Repertoire in Patients With Graft-Versus-Leukemia After Donor Lymphocyte Infusion.
Journal of Clinical Investigation
Medicine
Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Comments on the Article ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic St
British Journal of Haematology
Hematology
Comments on the Article: ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic S
British Journal of Haematology
Hematology
Concurrent Use of Blinatumomab and Donor Lymphocyte Infusion (DLI) for Treatment of Relapsed Precursor B Cell Acute Lymphoblastic Leukemia (Pre B ALL) After Allogeneic Hematopoietic Cell Transplant (HCT)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
